Canada and Japan Leading Innovation in Regenerative Medicine

THe article doesn't speak to the science, but rather the potential - especially economic - of stem cell therapy.

Consortium members representing key sectors of the regenerative industry include the McEwen Centre for Regenerative Medicine, a world-renowned centre for stem cell biology and regenerative medicine to treat conditions such as heart disease, diabetes, respiratory disease and spinal cord injury. Canada is also home to the Canadian Stem Cell Network, one of the most prodigious producers of preclinical stem cell research and publications.

CCRM to-date has performed due diligence on 200 cell therapy technologies from Canada and around the world. These include work by Canadian leaders such as Induce Biologics, Sernova, TRT, RepliCel Life Sciences, Insception Lifebank, Octane, Northern Therapeutics, Interface Biologics, Stemcell Technologies, Actium Research, Hemostemix and more.